Raysum Co., Ltd.

Tokyo Stock Exchange 8890.T

Raysum Co., Ltd. EBIT for the year ending March 31, 2024: USD 149.23 M

Raysum Co., Ltd. EBIT is USD 149.23 M for the year ending March 31, 2024, a 149.87% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Raysum Co., Ltd. EBIT for the year ending March 31, 2023 was USD -299.21 M, a 19.48% change year over year.
Raysum Co., Ltd. EBIT for the year ending March 31, 2022 was USD -371.61 M, a -45.98% change year over year.
Raysum Co., Ltd. EBIT for the year ending March 31, 2021 was USD -254.56 M, a 9.80% change year over year.
Raysum Co., Ltd. EBIT for the year ending March 31, 2020 was USD -282.23 M, a 14.28% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Tokyo Stock Exchange: 8890.T

Raysum Co., Ltd.

CEO	Mr. Tsuyoshi Komachi
IPO Date	April 5, 2001
Location	Japan
Headquarters	Kasumigaseki Common Gate West Tower
Employees	214
Sector	Health Care
Industries Hospitals & Clinics Venture Capital

Description

Raysum Co., Ltd. engages in the real estate investment business in Japan. It also operates community hostels; and a specialized surgery center that offers medical care services to assist the elderly. The company was formerly known as Recrm Research Co., Ltd. and changed its name to Raysum Co., Ltd. in 2008. Raysum Co., Ltd. was founded in 1992 and is based in Tokyo, Japan.

Key trends

Past 5 years